QIAGEN IPA

Investigating biomarkers with bulk and single-cell RNA-seq expression data

407 views October 01, 2024

QIAGEN Ingenuity Pathway Analysis (IPA) is designed to help you analyze and compare...

QIAGEN IPA

Extracting novel hypotheses and insights from single cell data

625 views May 20, 2022

Follow us on a journey of single cell data exploration. See how you can Process,...

QIAGEN OmicSoft and Biomedical Knowledge Base

Public single-cell RNA-seq data investigation using QIAGEN OmicSoft and...

417 views February 27, 2024

Single-cell RNA-sequencing (scRNA-seq) is widely used to investigate tissue...

QIAGEN IPA

QIAGEN Ingenuity Pathway Analysis (IPA) summer camp Part 3

432 views July 17, 2024

• Compare different experimental conditions (different ‘omics data, treatments, time...

QIAGEN IPA

New user training: Large dataset analysis and knowledge base queries using...

1,765 views December 09, 2025

Join us for a 90-minute training session for new users of QIAGEN IPA. Users will learn...

QIAGEN IPA

QIAGEN IPA new user training

328 views January 20, 2026

Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your...

QIAGEN IPA

QIAGEN IPA New User Training

369 views November 13, 2025

Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your...

QIAGEN IPA

QIAGEN IPA new user training

350 views October 22, 2025

Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your...

QIAGEN IPA

QIAGEN IPA new user training

192 views August 12, 2025

Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your...

QIAGEN IPA

Discovery from public data (GEO, SRA and more) using Ingenuity Pathway Analysis

542 views November 20, 2023

Per user feedback, we are hosting a comprehensive training on how to effectively use...

QIAGEN IPA

Make discoveries from public data (GEO, SRA and more) using QIAGEN Ingenuity...

756 views April 24, 2023

Slides from this training: https://qiagen.showpad.com/share/TgxuabZORvDS3uLGCJRGN You...